Related Experiment Videos
[Limb-saving surgery of malignant bone tumors using massive bone grafts]
1Dept. of Orthopaedic Surgery, Gifu University School of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1989
Summary
Massive bone grafting using autografts and/or frozen allografts is beneficial for limb-saving surgery in malignant bone tumors. This method achieved excellent prognosis in 80% of cases, with good bone union and stability.
Area of Science:
- Orthopedic Surgery
- Oncology
- Reconstructive Surgery
Background:
- Artificial materials in limb-saving surgery present challenges related to patient age, tolerance, and stability.
- Massive bone grafting is a potential alternative that warrants reconsideration for malignant bone tumors.
Observation:
- A retrospective study analyzed 10 patients with malignant bone tumors who underwent limb-saving surgery with massive bone grafting (autografts and/or frozen allografts) between 1968 and 1987.
- Patient diagnoses included osteosarcoma, mesenchymal chondrosarcoma, leiomyosarcoma, and malignant fibrous histiocytoma, all staged as II-B.
- The median follow-up period was 71 months.
Findings:
- 80% of cases showed an excellent prognosis according to the modified Amago evaluation method.
- Good bone union and stability were achieved in all cases.
- No immunological reactions were observed.
Implications:
- Massive bone grafting is a highly beneficial method for limb-saving surgery in malignant bone tumor cases.
- This technique offers a viable alternative to artificial materials, providing good functional outcomes.
- Further research may support broader adoption of massive bone grafting in orthopedic oncology.